The second annual Psychedelics as Medicine Conference will gather influential researchers and policy makers in Reykjavik, Iceland for a two-day conference.| Lucid News - Psychedelics, Consciousness Technology, and the Future of Wellness
Lykos Therapeutics details how it is addressing questions raised by FDA advisors during a June 4 advisory meeting and how it will apply these insights to its Risk Evaluation and Mitigation Strategy.| Lucid News - Psychedelics, Consciousness Technology, and the Future of Wellness
Lykos Therapeutics addresses concerns from FDA Advisors about MDMA-assisted therapy and presents a forward looking plan.| Lucid News - Psychedelics, Consciousness Technology, and the Future of Wellness
